Sharon Alroy‐Preis

5.1k total citations · 3 hit papers
26 papers, 2.4k citations indexed

About

Sharon Alroy‐Preis is a scholar working on Infectious Diseases, Health and Molecular Biology. According to data from OpenAlex, Sharon Alroy‐Preis has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Health and 5 papers in Molecular Biology. Recurrent topics in Sharon Alroy‐Preis's work include SARS-CoV-2 and COVID-19 Research (20 papers), Vaccine Coverage and Hesitancy (13 papers) and SARS-CoV-2 detection and testing (7 papers). Sharon Alroy‐Preis is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (20 papers), Vaccine Coverage and Hesitancy (13 papers) and SARS-CoV-2 detection and testing (7 papers). Sharon Alroy‐Preis collaborates with scholars based in Israel, United States and Germany. Sharon Alroy‐Preis's co-authors include Nachman Ash, Amit Huppert, Yinon M. Bar‐On, Laurence S. Freedman, Yair Goldberg, Micha Mandel, Ron Milo, Omri Bodenheimer, Emilia Anis and Luis Jódar and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Sharon Alroy‐Preis

22 papers receiving 2.3k citations

Hit Papers

Impact and effectiveness of mRNA BNT162b2 vaccine against... 2021 2026 2022 2024 2021 2021 2022 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
    2021 1.0k citations Eric J. Haas, Frederick J. Angulo et al. The Lancet profile →
  2. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
    2021 708 citations Yinon M. Bar‐On, Yair Goldberg et al. New England Journal of Medicine profile →
  3. Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
    2022 263 citations Yair Goldberg, Micha Mandel et al. New England Journal of Medicine profile →

Peers

Sharon Alroy‐Preis
Natalie Groves United Kingdom
Sivan Gazit Israel
Tal Patalon Israel
Victoria Indenbaum Israel
Farid Khan United States
Kaijie Pan United States
Yaling Hu China
Srinivas Rao Valluri United States
Carmit Rubin Israel
Nancy McClung United States
Natalie Groves United Kingdom
Sharon Alroy‐Preis
Citations per year, relative to Sharon Alroy‐Preis Sharon Alroy‐Preis (= 1×) peers Natalie Groves

Countries citing papers authored by Sharon Alroy‐Preis

Since Specialization
Citations

This map shows the geographic impact of Sharon Alroy‐Preis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Alroy‐Preis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Alroy‐Preis more than expected).

Fields of papers citing papers by Sharon Alroy‐Preis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Alroy‐Preis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Alroy‐Preis. The network helps show where Sharon Alroy‐Preis may publish in the future.

Co-authorship network of co-authors of Sharon Alroy‐Preis

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Alroy‐Preis. A scholar is included among the top collaborators of Sharon Alroy‐Preis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Alroy‐Preis. Sharon Alroy‐Preis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilboa, Mayan, Maylis Layan, Gili Joseph, et al.. (2025). Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS). The Journal of Infectious Diseases. 231(4). e734–e742.
2.
Joseph, Gili, Ili Margalit, Carmit Rubin, et al.. (2024). Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study. Viruses. 16(12). 1955–1955. 4 indexed citations
3.
Zuckerman, Neta S., Efrat Bucris, Oran Erster, et al.. (2024). Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study. The Lancet Microbe. 5(10). 100893–100893. 5 indexed citations
4.
Schwartz, Naama, et al.. (2024). Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study. European Journal of Pediatrics. 183(8). 3319–3326. 1 indexed citations
5.
Weil, Merav, Danit Sofer, Lester M. Shulman, et al.. (2023). Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. The Science of The Total Environment. 871. 161985–161985. 11 indexed citations
6.
Amir, Ofra, Yair Goldberg, Micha Mandel, et al.. (2023). Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster. Communications Biology. 6(1). 315–315. 2 indexed citations
7.
Amir, Ofra, Yair Goldberg, Micha Mandel, et al.. (2022). Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study. The Lancet Infectious Diseases. 23(1). 67–73. 12 indexed citations
8.
Goldberg, Yair, Micha Mandel, Yinon M. Bar‐On, et al.. (2022). Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2. New England Journal of Medicine. 386(23). 2201–2212. 263 indexed citations breakdown →
9.
Amir, Ofra, Yair Goldberg, Micha Mandel, et al.. (2022). Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine. Nature Communications. 13(1). 1971–1971. 7 indexed citations
10.
Haas, Eric J., John M. McLaughlin, Farid Khan, et al.. (2021). Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. The Lancet Infectious Diseases. 22(3). 357–366. 79 indexed citations
11.
Singer, Shepherd Roee, Frederick J. Angulo, David L. Swerdlow, et al.. (2021). Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine. 42. 101190–101190. 19 indexed citations
12.
Reicher, Shay, Yotam Shenhar, Michael Friger, et al.. (2021). Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. European Journal of Epidemiology. 36(7). 727–734. 21 indexed citations
13.
Haas, Eric J., Frederick J. Angulo, John M. McLaughlin, et al.. (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet. 397(10287). 1819–1829. 1042 indexed citations breakdown →
14.
Mor, Orna, Neta S. Zuckerman, Ronen Fluss, et al.. (2021). BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals. Journal of Clinical Epidemiology. 142. 38–44. 13 indexed citations
15.
Stein, Michal, Zachi Grossman, Tal Brosh‐Nissimov, et al.. (2021). How compassionate use enabled Israel to deliver the Pfizer‐BioNTech COVID‐19 vaccination to vulnerable children aged 12–15 years before regulatory approval. Acta Paediatrica. 111(4). 834–841.
16.
Singer, Shepherd Roee, Frederick J. Angulo, David L. Swerdlow, et al.. (2021). Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel. SSRN Electronic Journal. 2 indexed citations
17.
18.
Mor, Orna, Neta S. Zuckerman, Ronen Fluss, et al.. (2021). BNT162b2 Vaccination Efficacy is Marginally Affected by the SARS-CoV-2 B.1.351 Variant in Fully Vaccinated Individuals. SSRN Electronic Journal. 1 indexed citations
19.
20.
Daly, Elizabeth R., et al.. (2015). Taken to Court: Defending Public Health Authority to Access Medical Records during an Outbreak Investigation. Public Health Reports. 130(3). 278–283.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie Groves Breakdown of academic impact, for papers by Sivan Gazit Breakdown of academic impact, for papers by Tal Patalon Breakdown of academic impact, for papers by Victoria Indenbaum Breakdown of academic impact, for papers by Farid Khan Breakdown of academic impact, for papers by Kaijie Pan Breakdown of academic impact, for papers by Yaling Hu Breakdown of academic impact, for papers by Srinivas Rao Valluri Breakdown of academic impact, for papers by Carmit Rubin Breakdown of academic impact, for papers by Nancy McClung
Rankless by CCL
2026